Clinical Trial Update: Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1b multicenter trial evaluating carfilzomib in combination with lenalidomide and dexamethasone for relapsed multiple myeloma has completed; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Amgen | Conditions: Relapsed Multiple Myeloma | Phase 1 | Status: COMPLETED | Results posted: 2015-06-03